Follow The Filings

ARVN Arvinas Inc.

Health Care, filed as ARVINAS INC (COM), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by ARVN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ARVN insider trades
  • $268K bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Briggs Morrison Director
    Buy
    $268K 20,000 shares at $13.40 +26% to stake
    Traded Mar 6 Filed Mar 9

Also filed in the last 12 months, not counted as buying or selling: 23 sales to cover taxes and 11 stock grants.

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
8-K 5.07
8-K 5.02
8-K 8.01
8-K 7.01,8.01,9.01
8-K 1.01,7.01,9.01
8-K 2.02,9.01
10-Q
8-K 7.01,8.01,9.01
DEF 14A
DEFA14A
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 7.01,8.01,9.01

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Net income -$367.3M -$198.9M -$80.8M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $1.28B $1.07B $0.701B
Total non-current assets * $24.4M $24.1M $17.2M
Total assets $1.3B $1.09B $0.718B
Total current liabilities $257.1M $229.8M $142.5M
Total non-current liabilities * $387.5M $299.9M $141.5M
Total equity $660M $561.7M $433.9M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$347.8M -$259.3M -$273.8M
Cash from investing $203.5M $34.7M $407.6M
Cash from financing $374.7M $7.9M -$91.4M
Net change in cash $230.4M -$216.7M $42.4M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.